Recombinant Adenoviral Human p53 Gene
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Adenoviral Human p53 Gene, covering 2015-04-29 to 2015-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion [Phase 2]